From the 23rd of June 2025 we will be able to refer eligible patients to a new NHS weight loss service where Tirzepatide (Mounjaro®) can be prescribed to aid weight loss.
We can not prescribe this within primary care.
Only the following patients can be referred:
Have a BMI of 40 or more, and have at least four or more of the following health conditions:
+ High blood pressure treated with medication
+ Raised cholesterol treated with medication, or raised levels off medication
+ Obstructive sleep apnoea treated with CPAP
+ Cardiovascular disease- (example angina, heart attack, stroke, narrowed arteries in the legs, heart failure)
+ Type 2 diabetes mellitus
PLEASE WAIT UNTIL THE 23RD OF JUNE BEFORE CONTACTING US ABOUT A REFERRAL